Heart Attack News and Research

RSS

3D cluster of cells could enhance myocardial repair

Cell therapy for cardiac regeneration, while promising, has been hampered by issues with long-term survival of the transplanted cells.

15 Sep 2020

Biologic therapy for psoriasis could lead to significant reduction in heart disease

Patients with psoriasis treated with biologic therapy, which are protein-based infusions to suppress inflammation, had a significant reduction in high-risk plaque in heart arteries, over one-year, according to new research published today in Circulation: Cardiovascular Imaging, an American Heart Association journal.

15 Sep 2020

Identifying, preventing and treating drug-induced arrhythmias

Health care professionals should become more familiar with medications that cause irregular heart rhythms called arrhythmias, according to "Drug- Induced Arrhythmias," a new scientific statement from the American Heart Association, published today in the Association's flagship journal Circulation.

15 Sep 2020

Nonharmful stress promotes disease resilience in offspring, shows study

Research led by Jeff Gidday, PhD, Professor of Ophthalmology, Biochemistry, Neuroscience, and Physiology at LSU Health New Orleans School of Medicine, reports what is believed to be the first study in a mammalian model documenting the reprogramming of heritability to promote disease resilience in the next generation.

10 Sep 2020

Novel discovery could lead to stem cell-based treatment for heart failure

Blocking an enzyme linked with inflammation makes it possible for stem cells to repair damaged heart tissue, new research from UC Davis Health scientists shows.

10 Sep 2020

Scientists develop method for producing anti-inflammatory substances with controlled quality

Anti-inflammatory substances based on components of human cells could one day improve treatment in patients. Researchers at the Institute of Pharmacy at Martin Luther University Halle-Wittenberg (MLU) have developed a method for producing those substances with controlled quality.

10 Sep 2020

Study: Generic cholesterol medications save billions of dollars for Medicare

The switch from brand name to generic cholesterol medications that occurred between 2014 and 2018 has saved Medicare billions of dollars, even as the number of people on cholesterol-lowering drugs has increased, UT Southwestern scientists have calculated.

9 Sep 2020

American Heart Association honors UVA professor for contributions to cardiovascular research

Robert M. Carey, MD, Professor of Medicine at the University of Virginia School of Medicine, has been named a Distinguished Scientist of the American Heart Association for his "extraordinary contributions" to cardiovascular research.

8 Sep 2020

Study may provide the basis for better diagnostic, therapeutic approaches to blood diseases

The hemoglobin in the red blood cells ensures that our body cells receive sufficient oxygen. When the blood pigment is broken down, "heme" is produced, which in turn can influence the protein cocktail in the blood.

5 Sep 2020

Mount Sinai hospitals win top quality achievement awards for stroke and cardiac care

Seven Mount Sinai Health System hospitals have received top quality achievement awards from the American Heart Association for ensuring that patients with stroke, heart failure, and severe heart attacks receive the most appropriate and safest treatment for the best possible outcomes.

1 Sep 2020

Restrictive blood transfusion strategy has no negative impact on anemic heart attack patients

Restricting blood transfusion in anemic heart attack patients to those with very low hemoglobin levels saves blood with no negative impact on clinical outcomes.

1 Sep 2020

Low dose colchicine significantly reduces risk of cardiovascular death

An Australian-Dutch trial led by Perth GenesisCare cardiologists, Professor Peter Thompson and Dr Mark Nidorf, in collaboration with the Dutch Network for Cardiovascular Research (WCN) in the Netherlands, confirmed that low dose colchicine was safe, well-tolerated over the long-term, and significantly reduced the risk of cardiovascular death, heart attack, and ischemic stroke in patients with chronic coronary disease.

1 Sep 2020

Low dose colchicine significantly reduces risk of cardiovascular death

An Australian-Dutch trial led by Perth GenesisCare cardiologists, Professor Peter Thompson and Dr Mark Nidorf,

1 Sep 2020

Heart structure could explain why risk of heart disease differs between men and women

Differences in the shape and texture of men and women's hearts could potentially explain why their risk of heart disease differs, according to research funded by the British Heart Foundation (BHF).

1 Sep 2020

Blood pressure medication could be an effective tool for reducing cardiovascular risk

Blood pressure medication can prevent heart attacks and strokes - even in people with normal blood pressure. That's the finding of late breaking research presented in a Hot Line session today at ESC Congress 2020.

31 Aug 2020

Telemonitoring may reduce heart attack, stroke rate by 50% for people with high blood pressure

People enrolled in a pharmacist-led telemonitoring program to control high blood pressure were about half as likely to have a heart attack or stroke compared to those who received routine primary care, according to new research published today in Hypertension, an American Heart Association journal.

31 Aug 2020

Heart Attack News and Research

3D cluster of cells could enhance myocardial repair

Biologic therapy for psoriasis could lead to significant reduction in heart disease

Identifying, preventing and treating drug-induced arrhythmias

Nonharmful stress promotes disease resilience in offspring, shows study

Novel discovery could lead to stem cell-based treatment for heart failure

Scientists develop method for producing anti-inflammatory substances with controlled quality

Study: Generic cholesterol medications save billions of dollars for Medicare

American Heart Association honors UVA professor for contributions to cardiovascular research

Study may provide the basis for better diagnostic, therapeutic approaches to blood diseases

Mount Sinai hospitals win top quality achievement awards for stroke and cardiac care

Restrictive blood transfusion strategy has no negative impact on anemic heart attack patients

Low dose colchicine significantly reduces risk of cardiovascular death

Low dose colchicine significantly reduces risk of cardiovascular death

Heart structure could explain why risk of heart disease differs between men and women

Blood pressure medication could be an effective tool for reducing cardiovascular risk

Telemonitoring may reduce heart attack, stroke rate by 50% for people with high blood pressure

Gout medication reduces major cardiovascular events in heart patients

Premenopausal women have favorable long-term outcomes after heart attack, shows study

ESC publishes treatment guidelines for non-ST-segment elevation acute coronary syndrome

New guidelines cover leisure exercise and competitive sports for people with heart disease

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News